Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Kelly A. Kramer
Director
Disclosures on record
11
Companies involved
2
Disclosure history
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Director sold ~$357K of Gilead Sciences
Scheduled in advanceDirector sold ~$357K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.